Search
Leap Therapeutics Surges 300% on $50M Winklevoss-Backed Zcash Bet
12.11.2025
The company is also rebranding as Cypherpunk Technologies with ticker change to CYPH, effective Thursday
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token